| Weight | 1 lbs |
|---|---|
| Dimensions | 9 × 5 × 2 in |
| target | Coxiella burnetii Phase 2 reactive IgG |
| species reactivity | Coxiella burnetii (Q fever) |
| applications | ELISA |
| assay type | Indirect & quantitative |
| available size | 3 mL |
Coxiella burnetii Phase 2 IgG Control Serum BC1312G
$94.00
Summary
- Virion/Serion Diagnostic Kit Control for research use (RUO)
- Coxiella burnetii Phase 2 IgG Control Serum
- Applications: ELISA
- IgG control serum
- Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
- 3 mL
Coxiella burnetii Phase 2 IgG Control Serum BC1312G
| target relevance |
|---|
| human antibody anti-Coxiella burnetii1 |
Data
FAQ & Publications
Frequently Asked Questions
What is the primary application of the Coxiella burnetii Phase 2 IgG Control Serum BC1312G?
This control serum is primarily used as an IgG control in ELISA assays, specifically for SERION ELISA classic and SERION ELISA antigen assays targeting Coxiella burnetii Phase 2 IgG.
How should the Coxiella burnetii Phase 2 IgG Control Serum be stored to maintain its stability?
The serum should be stored at temperatures between 2-8°C to preserve its stability and ensure optimal performance in assays.
Is the Coxiella burnetii Phase 2 IgG Control Serum BC1312G ready to use directly in ELISA tests?
Yes, the control serum is provided ready-to-use and pre-diluted specifically for compatibility with SERION ELISA classic and SERION ELISA antigen assays.
Which organism's antibodies does the Coxiella burnetii Phase 2 IgG Control Serum target?
The serum targets IgG antibodies reactive against Coxiella burnetii Phase 2 antigens, the causative agent of Q fever.
Can this control serum be used to differentiate between acute and chronic Coxiella burnetii infections?
While this serum contains IgG antibodies against Phase 2 antigens typical of acute infection, differentiation of acute from chronic infections generally requires detection of antibodies against both Phase 1 and Phase 2 antigens; thus, this control serum is mainly relevant for assays detecting Phase 2 IgG in acute infection.
Publications
| pmid | title | authors | citation |
|---|---|---|---|
| We haven't added any publications to our database yet. | |||
Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.
Protocols
| relevant to this product |
|---|
| BC1312G protocol |
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.